Home › Job titles › Principal Statistical Programmer
Principal Statistical Programmer: H-1B salaries
271 labor condition applications used the job title Principal Statistical Programmer. Median offered base salary $140,795; middle half $128,157–$150,540.
Applications (LCAs)271
Median offered salary$140,795
Middle half of salaries$128,157–$150,540
10th–90th percentile$104,905–$167,155
Immigration lawyer, recruiter or employer? Feature your service at the top of this page — $99 for 30 days →
Employers
| Employer | LCAs | Median salary |
|---|
| IQVIA RDS Inc. | 38 | $150,565 |
| Cytel Inc. | 36 | $137,589 |
| Parexel International LLC | 26 | $147,420 |
| Safety & Efficacy IT Solutions Inc. | 21 | $102,500 |
| Regeneron Pharmaceuticals, Inc. | 15 | $150,000 |
| Fortrea Inc. | 11 | $125,694 |
| Vertex Pharmaceuticals Incorporated | 10 | $140,372 |
| Pfizer Inc. | 9 | $142,000 |
| Syneos Health, LLC | 8 | $137,218 |
| Intone Networks, Inc. | 8 | $132,500 |
| Labcorp Drug Development Inc. | 7 | $121,826 |
| Seagen Inc. | 7 | $142,000 |
| Pharmaceutical Research Associates, Inc. | 7 | $150,139 |
| Softworld, LLC | 6 | $129,147 |
| Alnylam US, Inc. | 5 | $170,000 |
| Fortrea Inc. f/k/a LabCorp Drug Development Inc. | 4 | $141,500 |
| TechData Service Company LLC | 4 | $148,000 |
| Motion Recruitment Partners, LLC | 4 | $142,230 |
| Jazz Pharmaceuticals, Inc. | 3 | $159,650 |
| Springworks Therapeutics Operating Company | 3 | $190,000 |
| Spartan Solutions Inc. | 3 | $93,580 |
| Sarepta Therapeutics, Inc. | 2 | $149,500 |
| Agios Pharmaceuticals, Inc. | 2 | $132,464 |
| Ipsen Bioscience, Inc. | 2 | $169,592 |
| Servier Bio-Innovation LLC | 2 | $161,407 |
| Travere Therapeutics, Inc. | 2 | $139,398 |
| Syndax Pharmaceuticals, Inc | 2 | $188,800 |
| Clinvia LLC | 2 | $168,600 |
| Everest Clinical Research Corporation | 2 | $157,326 |
| Novusscientia LLC | 1 | — |
| Terbium Technologies INC | 1 | $106,000 |
| Fortrea Inc. (Formerly d/b/a LabCorp Drug Development, Inc.) | 1 | $123,000 |
| Intellectt, Inc. | 1 | $117,000 |
| Ephicacy Consulting Group, Inc | 1 | $140,000 |
| Shionogi, Inc. | 1 | $128,000 |
| Intone Networks, Inc. d/b/a Intone | 1 | $150,000 |
| HSquare IT Solutions Inc | 1 | $79,747 |
| Roche Molecular Systems, Inc. | 1 | $115,898 |
| WCG Clinical, Inc. | 1 | $124,800 |
| Nixon Technologies LLC | 1 | $68,286 |
| Olema Pharmaceuticals, Inc. | 1 | $190,000 |
| Ipsen Biopharmaceuticals, Inc. | 1 | $169,592 |
| Medidata Solutions, Inc. | 1 | $182,571 |
| Krystal Biotech Inc. | 1 | $150,000 |
| Ocugen OpCo, Inc. | 1 | $113,776 |
| Feather Technologies Inc | 1 | $137,093 |
| ITSyntax Inc | 1 | $140,000 |
| Calsoft Labs Inc | 1 | $104,000 |
| Vitalminds Inc. | 1 | $141,000 |
By wage level
| Wage level | Median salary |
|---|
| Level I (entry) | $83,400 |
| Level II (qualified) | $124,800 |
| Level III (experienced) | $140,016 |
| Level IV (fully competent) | $146,501 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|
| FY2023 | 69 | $140,000 |
| FY2024 | 69 | $142,000 |
| FY2025 | 69 | $135,450 |
| FY2026 | 55 | $150,000 |
Cities
- Durham, NC22
- Apex, NC14
- Roundrock, TX14
- Morrisville, NC11
- Cary, NC9
- Bothell, WA9
- Cambridge, MA8
- Fuquay Varina, NC6
- Raleigh, NC6
- Warren, NJ6
- Boston, MA5
- Holly Springs, NC5
- Tarrytown, NY5
- South San Francisco, CA4
- Austin, TX4
- Basking Ridge, NJ4
- Aubrey, TX4
- San Diego, CA3
- Irving, TX3
- Medina, MN3
- Overland Park, KS3
- Garner, NC3
- Newark, DE2
- Hutto, TX2
- Philadelphia, PA2
- Buffalo, NY2
- Bartlesville, OK2
- Aurora, IL2
- Waltham, MA2
- Westfield, IN2
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).